Guardant Health, Inc. is a precision oncology company engaged in the treatment
of cancer through the use of proprietary blood-based tests, vast data sets, and
advanced analytics. Its solutions include treatment selection, recurrence
detection, and early detection. The company was founded by Helmy Eltoukhy,
AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in
Palo Alto, CA.
